General Dynamics Corporation vs Medpace Holdings Inc — how do they compare? General Dynamics Corporation trades at $393.49 (market cap $106.03B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: General Dynamics Corporation is far larger — about 6.3× Medpace Holdings Inc's market cap, and General Dynamics Corporation pays a 1.62% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| GD | MEDP | |
|---|---|---|
Market Cap | $106.03B | $16.90B |
Sector | Industrials | Technology |
52-Week High | $395.97 | $620.59 |
52-Week Low | $312.53 | $393.42 |
Enterprise Value | $111.17B | $16.52B |
Dividend Yield | 1.62% | — |
Signals from Pluang's Aura AI — not financial advice
General Dynamics (GD) trades at $395.97, up 1.0% on the day, near its 52-week high. The stock shows bullish technical momentum with consistent earnings beats, including Q2 2026 EPS of $4.24 versus $3.96 expected. Revenue growth is robust, with 2025 revenue at $52.55 billion, and the company secured a major $76.6 billion Navy contract in July 2026, boosting its backlog.
Outlook remains positive driven by defense budget tailwinds and strong contract wins, but valuation multiples like a P/E of 23.9 suggest limited upside from current levels. Risks include execution on large contracts and macroeconomic pressures on government spending.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
General Dynamics is a defense contractor and business jet manufacturer. The firm's segments include aerospace, combat systems, marine, and technologies. The company's aerospace segment creates Gulfstream business jets. Combat system produces land-based combat vehicles, such as the M1 Abrams tank. The marine subsegment creates nuclear-powered submarines, among other things. The technologies segment contains two main units, an IT business that primarily serves the government market and a mission systems business that focuses on products that provide command, control, computers, intelligence, surveillance, and reconnaissance capabilities to the military.
Read more on GD →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →